Chemoinformaics analysis of 1-(4-Hydroxyphenyl)-2-(2-pyrrolidinyl) ethanone
Molecular Weight | 205.257 | nRot | 3 |
Heavy Atom Molecular Weight | 190.137 | nRig | 12 |
Exact Molecular Weight | 205.11 | nRing | 2 |
Solubility: LogS | -1.887 | nHRing | 1 |
Solubility: LogP | 0.971 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 32.7459 |
nHD | 2 | BPOL | 16.4861 |
QED | 0.739 |
Synth | 2.591 |
Natural Product Likeliness | 0.765 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.008 |
HIA | 0.022 |
CACO-2 | -4.685 |
MDCK | 0.00000796 |
BBB | 0.078 |
PPB | 0.200695 |
VDSS | 2.342 |
FU | 0.795036 |
CYP1A2-inh | 0.159 |
CYP1A2-sub | 0.642 |
CYP2c19-inh | 0.109 |
CYP2c19-sub | 0.3 |
CYP2c9-inh | 0.018 |
CYP2c9-sub | 0.215 |
CYP2d6-inh | 0.391 |
CYP2d6-sub | 0.831 |
CYP3a4-inh | 0.021 |
CYP3a4-sub | 0.23 |
CL | 14.498 |
T12 | 0.764 |
hERG | 0.084 |
Ames | 0.139 |
ROA | 0.84 |
SkinSen | 0.766 |
Carcinogencity | 0.424 |
EI | 0.058 |
Respiratory | 0.452 |
NR-Aromatase | 0.007 |
Antiviral | No |
Prediction | 0.643462 |